β-catenin (Ctnnb1) gene mutations in diethylnitrosamine (DEN)-induced liver tumors in male F344 rats

Japanese Journal of Cancer Research

Volumn 90, Issue 8, 1999, Pages 824-828

  Yamada, Yasuhiro ^a   Yoshimi, Naoki ^a   Sugie, Shigeyuki ^a   Suzui, Masumi ^a   Matsunaga, Kengo ^a   Kawabata, Kunihiro ^a   Hara, Akira ^a   Mori, Hideki ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Diethylnitrosamine; Hepatocarcinogenesis; Mutation; Rat; catenin

Indexed keywords

BETA CATENIN; DIETHYLNITROSAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CODON; CONTROLLED STUDY; EXON; GENE MUTATION; LIVER ADENOMA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; NONHUMAN; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0032873901     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00822.x     Document Type: Article

References (38)

1. Molenaar, M., Wetering, M. V. D., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O. and Clevers, H. XTcf-3 transcription factor mediates β-catenin-induced axis formation in Xenopus embryos. Cell, 86, 391-399 (1996).
2. Behrens, J., Kries, J. V., Kuhl, M., Bruhn, L., Wedlich, D., Grosschedl, R. and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEF-1. Nature, 382, 638-642 (1996).
3. Korinek, V., Barker, N., Morin, P., Wichen, D. V., Weger, R. D., Kinzler, K., Vogelstein, B. and Clevers, H. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/-colon carcinoma. Science, 275, 1784-1787 (1997).
4. Wetering, M. V. D., Cavallo, R., Dooijes, D., Beest, M. V., Es, J. V., Loureiro, J., Ypma, A., Hursh, D., Jones, T., Bejsovec, A., Peifer, M., Mortin, M. and Clevers, H. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell, 88, 789-799 (1997).
5. Jeon, S., Jeong, S., Lee, C., Kim, J., Kim, Y., Chung, H., Park, S. and Seong, R. Expression of Tcf-1 mRNA and surface TCR-CD3 complexes are reduced during apoptosis of T cells. Int. Immunol, 10, 1519-1527 (1998).
6. Young, C., Kitamura, M., Hardy, S. and Kitajewski, J. Wnt-1 induces growth, cytosolic β-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts. Mol. Cell. Biol., 18, 2474-2485 (1998).
7. Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804 (1997).
8. Orford, K., Crockett, C., Jensen, J., Weissman, A. and Byers, S. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272, 24735-24738 (1997).
9. Morin, P., Sparks, A., Korinek, V., Barker, N., Clevers, H., Vogelstein, B. and Kinzler, K. Activation of β-catenin-Tcf signaling in colon cancer by mutations in ß-catenin or APC. Science, 275, 1787-1790 (1997).
10. Zurawel, R., Chiappa, S., Allen, C. and Raffel, C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res., 58, 896-899 (1998).
11. Palacios, J. and Gamallo, C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res., 58, 1344-1347 (1998).
12. Voeller, H., Truica, C. and Gelmann, E. β-Catenin mutations in human prostate cancer. Cancer Res., 58, 2520-2523 (1998).
13. Dragan, Y., Hully, J., Nakamura, J., Mass, M., Swenberg, J. and Pitot, H. Biochemical events during initiation of rat hepatocarcinogenesis. Carcinogenesis, 15, 1451-1458 (1994).
14. Tanaka, T., Kojima, T., Kawamori, T., Yoshimi, N. and Mori, H. Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res., 53, 2775-2779 (1993).
15. Nakae, D., Kobayashi, Y., Akai, H., Andoh, N., Satoh, H., Ohashi, K., Tsutsumi, M. and Konishi, Y. Involvement of 8-hydroxyguanine formation in the initiation of rat liver carcinogenesis by low dose levels of N-nitrosodiethylamine. Cancer Res., 57, 1281-1287 (1997).
16. Omori, Y., Krutovskikh, V., Mironov, N., Tsuda, H. and Yamasaki, H. Cx32 gene mutation in a chemically induced rat liver tumour. Carcinogenesis, 17, 2077-2080 (1996).
17. Mills, J., Falls, J., Souza, A. D. and Jirtle, R. Imprinted M6p/Igf2 receptor is mutated in rat liver tumors. Oncogene, 16, 2797-2802 (1998).
18. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Imaoka, S., Murata, M., Shimano, T. and Nakamura, Y. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res., 58, 2524-2527 (1998).
19. Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C., Buendia, M., Soubrane, O., Fabre, M., Chelly, J., Beldjord, C., Kahn, A. and Perret, C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 95, 8847-8851 (1998).
20. Takahashi, M., Fukuda, K., Sugimura, T. and Wakabayashi, K. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58, 42-46 (1998).
21. Suzui, M., Yoshimi, N., Dashwood, R., Ushijima, T., Sugimura, T., Mori, H. and Nagao, M. Frequent mutations in the rat β-catenin gene (Ctnnb1) of ulcerative colitis-associated colon cancer induced by 1-hydroxyanthraquinone and methylazoxymethanol acetate. Mol. Carcinog., 24, 232-237 (1999).
22. Dashwood, R., Suzui, M., Nakagama, H., Sugimura, T. and Nagao, M. High frequency of β-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58, 1127-1129 (1998).
23. Squire, R. and Levitt, M. Report of a workshop on classification of specific hepatocellular lesions in rats. Cancer Res., 35, 3214-3223 (1975).
24. Maronpot, R., Montgomery, C., Boorman, G. and McConnell, E. National toxicology program nomenclature for hepatoproliferative lesions of rats. Toxicol. Pathol., 14, 263-273 (1986).
25. Iwao, K., Nakamori, S., Kameyama, M., Imaoka, S., Kinoshita, M., Fukui, T., Ishiguro, S., Nakamura, Y. and Miyoshi, Y. Activation of the β-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res., 58, 1021-1026 (1998).
26. Ilyas, M., Tomlinson, I., Rowan, A., Pignatelli, M. and Bodmer, W. β-Catenin mutations in cell lines established from human colorectal cancers. Proc. Natl. Acad. Sci. USA, 94, 10330-10334 (1997).
27. Sparks, A., Morin, P., Vogelstein, B. and Kinzler, K. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res., 58, 1130-1134 (1998).
28. Yost, C., Torres, M., Miller, J., Huang, E., Kimelman, D. and Moon, R. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev., 10, 1443-1454 (1996).
29. Munemitsu, S., Albert, I., Rubinfeld, B. and Polakis, P. Deletion of an amino-terminal sequence β-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein. Mol. Cell. Biol., 16, 4088-4094 (1996).
30. Aberle, H., Bauer, A., Stappert, J., Kispert, A. and Kemler, R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16, 3797-3804 (1997).
31. He, T., Sparks, A., Rago, C., Hermeking, H., Zawel, L., Costa, L. D., Morin, P., Vogelstein, B. and Kinzler, K. Identification of c-MYC as a target of the APC pathway. Science, 281, 1509-1512 (1998).
32. Beer, D., Schwarz, M., Sawada, N. and Pitot, H. Expression of H-ras and c-myc protooncogenes in isolated gammaglutamyl transpeptidase-positive rat hepatocytes and in hepatocellular carcinomas induced by diethylnitrosamine. Cancer Res., 46, 2435-2441 (1986).
33. Himeno, Y., Fukuda, Y., Hatanaka, M. and Imura, H. Expression of oncogenes during rat chemical hepatotumorigenesis promoted by estrogen. Jpn. J. Cancer Res., 80, 737-742 (1989).
34. Pascale, R., Miglio, M. D., Muroni, M., Simile, M., Daino, L., Seddaiu, M., Nufris, A., Gaspa, L., Deiana, L. and Feo, F. c-Myc amplification in pre-malignant and malignant lesions induced in rat liver by the resistant hepatocyte model. Int. J. Cancer, 68, 136-142 (1996).
35. Hirota, N. and Williams, G. The sensitivity and heterogeneity of histochemical markers for altered foci involved in liver carcinogenesis. Am. J. Pathol., 95, 317-328.
36. Vogelstein, B. and Kinzler, K. "The Genetic Basis of Human Cancer," pp. 565-587 (1998). McGraw-Hill, New York.
37. Su, L., Kinzler, K., Vogelstein, B., Preisinger, A., Moser, A., Luongo, C., Gould, K. and Dove, W. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science, 256, 668-670 (1992).
38. Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. and Taketo, M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad. Sci. USA, 92, 4482-4486 (1995).